Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Long-Term Investments: 2014-2020

Historic Long-Term Investments for Fortress Biotech (FBIO) over the last 6 years, with Dec 2020 value amounting to $17.6 million.

  • Fortress Biotech's Long-Term Investments rose 385.03% to $56.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $56.9 million, marking a year-over-year increase of 385.03%. This contributed to the annual value of $17.6 million for FY2020, which is 57.57% up from last year.
  • Latest data reveals that Fortress Biotech reported Long-Term Investments of $17.6 million as of FY2020, which was up 57.57% from $11.1 million recorded in FY2019.
  • Fortress Biotech's Long-Term Investments' 5-year high stood at $17.6 million during FY2020, with a 5-year trough of $1.4 million in FY2017.
  • Moreover, its 2-year median value for Long-Term Investments was $14.4 million (2019), whereas its average is $14.4 million.
  • In the last 5 years, Fortress Biotech's Long-Term Investments slumped by 41.03% in 2017 and then surged by 57.57% in 2020.
  • Fortress Biotech's Long-Term Investments (Yearly) stood at $2.4 million in 2016, then slumped by 41.03% to $1.4 million in 2017, then reached $11.1 million in 2019, then spiked by 57.57% to $17.6 million in 2020.